These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21318144)

  • 1. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels.
    Chu CH; Lam HC; Lee JK; Lu CC; Sun CC; Wang MC; Chuang MJ
    J Thyroid Res; 2011 Jan; 2011():194721. PubMed ID: 21318144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
    Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves' disease women.
    Siemińska L; Foltyn W; Głogowska-Szeląg J; Kajdaniuk D; Marek B; Nowak M; Walczak K; Kos-Kudła B
    Endokrynol Pol; 2013; 64(1):26-9. PubMed ID: 23450444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
    Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
    J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal.
    Lin SY; Huang SC; Sheu WH
    Metabolism; 2010 Feb; 59(2):195-9. PubMed ID: 19765779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.
    Iglesias P; Alvarez Fidalgo P; Codoceo R; Díez JJ
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):621-9. PubMed ID: 14616887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism.
    El Gawad SS; El Kenawy F; Mousa AA; Omar AA
    Endocr Pract; 2012; 18(3):376-81. PubMed ID: 21742599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and its correlation with chemerin and visfatin in Saudi patients with hyperthyroidism.
    Al Doghaither HA; Alshaikh EM; Omar UM; Alsufiani HM; Mansouri RA; Tarbiah NI; Alshaikh AA; Alshaikh AM
    Int J Health Sci (Qassim); 2019; 13(5):18-21. PubMed ID: 31501648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin response to oral glucose load in hyperthyroidism, before and after treatment with antithyroid drugs.
    Theodoropoulou A; Psyrogiannis A; Metallinos IC; Habeos I; Vgenakis AG; Kyriazopoulou V
    J Endocrinol Invest; 2009 Feb; 32(2):94-7. PubMed ID: 19411802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function.
    Hsieh CJ; Wang PW
    Endocr J; 2008 Jul; 55(3):489-94. PubMed ID: 18469483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women.
    Iacobellis G; Ribaudo MC; Zappaterreno A; Iannucci CV; Leonetti F
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):487-91. PubMed ID: 15807881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance assessed with HOMA-IR in hyperthyroid patients].
    Owecki M; Nikisch E; Sowiński J
    Pol Merkur Lekarski; 2005 Nov; 19(113):617-20. PubMed ID: 16498796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects.
    Yu H; Yang Y; Zhang M; Lu H; Zhang J; Wang H; Cianflone K
    Nutr Metab (Lond); 2006 Feb; 3():13. PubMed ID: 16472384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.